When medicine is written in code, how do you market the cure? A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms? In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape. Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: ¿ What digital therapeutics are - and how they differ from wellness apps. ¿ Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks. ¿ How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs. ¿ Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health. ¿ The role of AI, wearables, and telemedicine in scaling digital care. ¿ Strategic frameworks for commercialization, adoption, and measuring success. Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded. Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 52882357-n
Quantité disponible : Plus de 20 disponibles
Vendeur : BargainBookStores, Grand Rapids, MI, Etats-Unis
Paperback or Softback. Etat : New. Code to Cure: Digital Therapeutics and the Future of Pharma. Book. N° de réf. du vendeur BBS-9789347311147
Quantité disponible : 5 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 52882357
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9789347311147
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 52882357-n
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 52882357
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Hardcover. Etat : new. Hardcover. When medicine is written in code, how do you market the cure?A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: - What digital therapeutics are - and how they differ from wellness apps.- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.- The role of AI, wearables, and telemedicine in scaling digital care.- Strategic frameworks for commercialization, adoption, and measuring success.Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9789347311147
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering. N° de réf. du vendeur 9789347311147
Quantité disponible : 2 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Code to Cure | Digital Therapeutics and the Future of Pharma | Subba Rao Chaganti | Taschenbuch | Englisch | 2026 | PharmaMed Press | EAN 9789347311147 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 134649663
Quantité disponible : 5 disponible(s)